Once-Weekly Semaglutide Reduces HbA1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Common OAD: a Subgroup Analysis from SUSTAIN 2–4 and 10
Crossref DOI link: https://doi.org/10.1007/s13300-020-00796-z
Published Online: 2020-03-19
Published Print: 2020-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Capehorn, Matthew
Ghani, Yasmin
Hindsberger, Charlotte
Johansen, Pierre
Jódar, Esteban
Funding for this research was provided by:
Novo Nordisk
Text and Data Mining valid from 2020-03-19
Version of Record valid from 2020-03-19
Article History
Received: 31 January 2020
First Online: 19 March 2020